Hamburg, Germany, 06 September 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at the Morgan Stanley 15th Annual Global Healthcare Conference in New York, USA; 6th German Corporate Conference, Berenberg/Goldman Sachs in Munich, Germany, and Baader Investment Conference, Munich, Germany, and will be attending Goldman Sachs' 7th Annual Biotech Symposium in London, UK, and Bank of America Merrill Lynch Global Healthcare Conference 2017 in London, UK. 

Goldman Sachs' 7th Annual Biotech Symposium, London, UK 

- Date: Friday, 08 September 2017
- Venue: London, UK
- Attendee: Enno Spillner, Chief Financial Officer of Evotec AG 

Morgan Stanley 15th Annual Global Healthcare Conference, New York, USA 

- Date: Monday, 11 September 2017, 04.50 pm EDT (09.50 pm BST, 10.50 pm CEST)
- Venue: New York, NY, USA
- Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG 

Bank of America Merrill Lynch Global Healthcare Conference 2017, London, UK 

- Date: Thursday, 14 September 2017
- Venue: London, UK
- Attendee: Enno Spillner, Chief Financial Officer of Evotec AG 

6th German Corporate Conference, Berenberg/Goldman Sachs, Munich, Germany 

- Date: Monday, 18 September 2017, 11.00 am CEST (10.00 am BST, 05.00 am EDT)
- Venue: Munich, Germany
- Attendee: Enno Spillner, Chief Financial Officer of Evotec AG 

Baader Investment Conference, Munich, Germany 

- Date: Wednesday, 20 September 2017, 05.15 pm CEST (04.15 am BST, 11.15 am EDT)
- Venue: Munich, Germany
- Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG 

FORWARD LOOKING STATEMENTS

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.